Archives of Gerontology and Geriatrics
Volume 53, Issue 2 , Pages e106-e110 , September 2011

Clinical manifestations of elderly patients with digitalis intoxication in the emergency department

  • Salvador Pita-Fernández

      Affiliations

    • Clinical Epidemiology and Biostatistics Unit, University Hospital Complex, A Coruña, As Xubias de Arriba 84, 15006 A Coruña, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 981 178 217; fax: +34 981 178 217.
    • ,
  • Mónica Lombardía-Cortiña

      Affiliations

    • Emergency Department, University Hospital Complex, A Coruña, As Xubias de Arriba 84, 15006 A Coruña, Spain
    • ,
  • Domingo Orozco-Veltran

      Affiliations

    • Chair of Family Medicine, Department of Medicine, Division of Geriatrics, Miguel Hernández University, Crta. Nacional, N-332 s/n, Sant Joan, 03550 Alicante, Spain
    • ,
  • Vicente Gil-Guillén

      Affiliations

    • Chair of Family Medicine, Department of Medicine, Division of Geriatrics, Miguel Hernández University, Crta. Nacional, N-332 s/n, Sant Joan, 03550 Alicante, Spain

Received 16 April 2010 ,Revised 1 July 2010 ,Accepted 11 July 2010.

References 

  1. Aarnoudse AL, Dieleman JP, Stricker BH. Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Safety. 2007;30:431–436
  2. Antman EM, Wenger TL, Butler , Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990;81:1744–1752
  3. Beller GA, Smith TW, Abelmann WH, Haber E, Hood . Digitalis intoxication. A prospective clinical study with serum level correlations. N. Engl. J. Med. 1971;284:989–997
  4. Bonilla-Porras M, Lucena Campillo MA, Delgado Silveira E, Ramallal Jiménez Del Llano MC, García Díaz B. Intoxicacion digitalica secundaria al tratamiento con claritromicina. Farm. Hosp. 2005;29:209–213(in Spanish)
  5. Cusack B, Kelly J, O’Malley K, Noel J, Lavan J, Horgan J. Digoxin in the elderly: pharmacokinetic consequences of old age. Clin. Pharmacol. Ther. 1979;25:772–776
  6. Delk C, Holstege CP, Brady WJ. Electrocardiographic abnormalities associated with poisoning. Am. J. Emerg. Med. 2007;25:672–687
  7. Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging. 2000;17:353–362
  8. Haynes K, Heitjan D, Kanetsky P, Hennessy S. Declining public health burden of digoxin toxicity from 1991 to 2004. Clin. Pharmacol. Ther. 2008;84:90–94
  9. Heinrich K, Prendergast HM, Erickson T. Chronic digoxin toxicity and significantly elevated BNP levels in the presence of mild heart failure. Am. J. Emerg. Med. 2005;23:561–562
  10. Honrubia A, Andrés JM, Alcaine F, Bonasa E, Fernández J, Luján B. Alteraciones visuales inducidas por digoxina con niveles terapeuticos. Arch. Soc. Esp. Oftalmol. 2000;75:55–56(in Spanish)
  11. Hornestam B, Jerling M, Karlsson MO, Held P DAAF Trial Group. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the digitalis in acute atrial fibrillation trial. Eur. J. Clin. Pharmacol. 2003;58:747–755
  12. Kiley CA, Cragin DJ, Roth BJ. Omeprazole-associated digoxin toxicity. South Med. J. 2007;100:400–402
  13. Klein-Schwartz W, Oderda GM. Poisoning in the elderly epidemiological, clinical and management considerations. Drugs Aging. 1991;1:67–89
  14. Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J. Emerg. Med. 2001;20:145–152
  15. Mahajan N, Mahboobi S, Mopala P, Lichstein E, Thekkoott D. Digoxin toxicity in renal failure: role of the electrocardiogram. Br. J. Hosp. Med. (Lond). 2007;68:216–217
  16. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br. J. Clin. Pharmacol. 2004;57:6–14
  17. Matzke GR, Frye RF. Drug administration in patients with renal insufficiency minimising renal and extrarenal toxicity. Drug Safety. 1997;16:205–231
  18. Medina-González L, Fuentes Ferrer ME, Suárez Llanos JP, Arranz Peña MI, Ochoa Mangado E. Epidemiologia de las intoxicaciones medica-mentosas durante un año en el Hospital Universitario Ramon y Cajal. Rev. Clin. Esp. 2008;9:432–436(in Spanish)
  19. Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann. Pharmacother. 2000;34:427–432
  20. Munidasa UA, Gawarammana IB, Kularatne SA, Kumarasiri PV, Goonasekera CD. Survival pattern in patients with acute organophosphate poisoning receiving intensive care. J. Toxicol. Clin. Toxicol. 2004;42:343–347
  21. Oishi A, Miyamoto K, Kashii S, Yoshimura N. Photopsia as a manifestation of digitalis toxicity. Can. J. Ophthalmol. 2006;41:603–604
  22. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J. Am. Geriatr. Soc. 1997;45:968–974
  23. Rodríguez-Calvo MS, Rico R, López-Rivadulla M, Suárez-Peñaranda JM, Muñoz JI, Concheiro L. Report of a suicidal digoxin intoxication: a case report. Med. Sci. Law. 2002;42:265–268
  24. Wofford JL, Ettinger WH. Risk factors and manifestations of digoxin toxicity in the elderly. Am. J. Emerg. Med. 1991;9(Suppl. 1):11–15

PII: S0167-4943(10)00189-5

doi: 10.1016/j.archger.2010.07.003

Archives of Gerontology and Geriatrics
Volume 53, Issue 2 , Pages e106-e110 , September 2011

Article Tools

* Image Usage & Resolution